AI can detect specks of lung cancer with 95% accuracy

A team of engineers has developed an artificial intelligence (AI) system that can find lung cancer on CT scans with 95 percent accuracy.

The team, from the University of Central Florida’s Center for Research in Computer Vision, taught a computer how to detect a tiny specks of lung cancer, which are often difficult for radiologists to identify, on CT scans.

“Successful diagnosis and treatment of lung cancer is highly dependent on early detection of lung nodules. Radiologists are analyzing an ever increasing amount of imaging data every day,” the team’s study said. “Computer-aided detection (CAD) systems are designed to help radiologists in the screening process. However, automatic detection of lung nodules with CAD remains a challenging task.”

According to the study, the engineers developed a completely 3D deep network architecture that was designed to detect lung nodules using a single-shot, single-scale algorithm. The researchers fed more than 1,000 CT scans into the AI software to help it learn to look for tumors. 

The team also taught the system how to ignore other tissues it encountered in CT scans and analyze lung tissues. According to a press release, the AI system is about 95 percent accurate, while humans are about 65 percent accurate.

“I believe this will have a very big impact,” Ulas Bagci, an Engineering Assistant Professor, said in the release. “Lung cancer is the number one cancer killer in the United States and if detected in late stages, the survival rate is only 17 percent. By finding ways to help identify earlier, I think we can help increase survival rates.”

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”